Susquehanna International Group
ACER

Susquehanna International Group’s Acer Therapeutics Inc ACER Stock Holding History

Susquehanna International Group’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-55,500
Closed -$46.1K – 13681
2023
Q3 		$46.1K Buy
+55,500
New +$45.6K ﹤0.01% 11336
2021
Q3 		– Sell
-27,600
Closed -$79K – 13820
2021
Q2 		$79K Sell
27,600
-6,700
-20% -$19.3K ﹤0.01% 12181
2021
Q1 		$107K Buy
+34,300
New +$117K ﹤0.01% 11828

Other funds holding ACER

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Susquehanna International Group's ACER Position: Q4 2023 in Review

Susquehanna International Group sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 290,372 shares — an estimated $240K sold.

Susquehanna International Group first reported a position in ACER in Q4 2018 and held it in 7 quarters. The position peaked at $598K in Q1 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

  • Susquehanna International Group reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 290,372 Acer Therapeutics Inc shares in Q4 2023, an estimated $240K.
  • Susquehanna International Group first reported a position in Acer Therapeutics Inc in Q4 2018 and held it in 7 quarters.
  • Susquehanna International Group's Acer Therapeutics Inc position peaked at $598K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.